Lazard Asset Management
AGN

Lazard Asset Management’s Allergan plc AGN Stock Holding History

Lazard Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12
Closed -$2K – 1608
2019
Q2 		$2K Hold
12
– – ﹤0.01% 1184
2019
Q1 		$1K Sell
12
-996
-99% -$144K ﹤0.01% 1138
2018
Q4 		$134K Buy
1,008
+673
+201% +$110K ﹤0.01% 895
2018
Q3 		$63K Sell
335
-195
-37% -$35.8K ﹤0.01% 942
2018
Q2 		$88K Sell
530
-67,933
-99% -$10.9M ﹤0.01% 915
2018
Q1 		$11.5M Sell
68,463
-2,378
-3% -$399K 0.02% 405
2017
Q4 		$11.6M Sell
70,841
-742,708
-91% -$133M 0.02% 415
2017
Q3 		$167M Sell
813,549
-342,268
-30% -$79.6M 0.3% 74
2017
Q2 		$281M Sell
1,155,817
-75,461
-6% -$17.7M 0.53% 51
2017
Q1 		$294M Buy
1,231,278
+57,724
+5% +$13.4M 0.56% 51
2016
Q4 		$246M Sell
1,173,554
-2,146,052
-65% -$445M 0.5% 55
2016
Q3 		$765M Buy
3,319,606
+1,178,080
+55% +$288M 1.52% 14
2016
Q2 		$495M Buy
2,141,526
+2,101,665
+5,272% +$485M 1.04% 26
2016
Q1 		$10.7M Buy
39,861
+3,025
+8% +$866K 0.02% 365
2015
Q4 		$11.5M Buy
36,836
+18,730
+103% +$5.58M 0.03% 355
2015
Q3 		$4.92M Buy
18,106
+17,886
+8,130% +$5.49M 0.01% 487
2015
Q2 		$66K Sell
220
-1,700
-89% -$507K ﹤0.01% 954
2015
Q1 		$570K Buy
1,920
+339
+21% +$96.7K ﹤0.01% 752
2014
Q4 		$406K Buy
1,581
+28
+2% +$7K ﹤0.01% 839
2014
Q3 		$374K Buy
+1,553
New +$348K ﹤0.01% 769
2014
Q2 		– Sell
-1,512
Closed -$311K – 1085
2014
Q1 		$311K Sell
1,512
-5,835
-79% -$1.16M ﹤0.01% 779
2013
Q4 		$1.23M Buy
+7,347
New +$1.15M ﹤0.01% 686

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lazard Asset Management's AGN Position: Q3 2019 in Review

Lazard Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 12 shares — an estimated $2K sold.

Lazard Asset Management first reported a position in AGN in Q4 2013 and held it in 22 quarters. The position peaked at $765M in Q3 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Lazard Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Lazard Asset Management sold 12 Allergan plc shares in Q3 2019, an estimated $2K.
  • Lazard Asset Management first reported a position in Allergan plc in Q4 2013 and held it in 22 quarters.
  • Lazard Asset Management's Allergan plc position peaked at $765M in Q3 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.